{"protocolSection":{"identificationModule":{"nctId":"NCT02677818","orgStudyIdInfo":{"id":"2014-YXB-001"},"organization":{"fullName":"Zhujiang Hospital","class":"OTHER"},"briefTitle":"The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet"},"statusModule":{"statusVerifiedDate":"2021-07","overallStatus":"WITHDRAWN","whyStopped":"No participants enrolled","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-05"},"primaryCompletionDateStruct":{"date":"2018-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-08","type":"ESTIMATED"},"studyFirstSubmitDate":"2016-02-05","studyFirstSubmitQcDate":"2016-02-05","studyFirstPostDateStruct":{"date":"2016-02-09","type":"ESTIMATED"},"lastUpdateSubmitDate":"2022-03-22","lastUpdatePostDateStruct":{"date":"2022-04-04","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Zhujiang Hospital","class":"OTHER"},"collaborators":[{"name":"Guangdong Province, Department of Science and Technology","class":"OTHER_GOV"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether Plasma Factor VIII Levels are related to the treatment of bleeding in ischemic stroke（IS）.","detailedDescription":"Clear cerebral infarction patients during hospitalization, treatment process, discharge and hemorrhage occurs, the stages F VIII level change and its correlation with bleeding adverse reactions. Analysis F VIII whether belong to hemorrhage occurs independent risk factors of adverse drug reactions,as well as the feasibility of predicting bleeding occurred adverse reaction index."},"conditionsModule":{"conditions":["Bleeding","Ischemic Stroke"],"keywords":["Plasma Factor VIII Levels","Ischemic stroke","Antithrombotic therapy","Bleeding"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"experimental group","description":"The risk of bleeding adverse reactions when FVIII below the normal level."},{"label":"control group","description":"The risk of bleeding adverse reactions when FVIII in normal level."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The levels of FVIII are measured by enzyme-linked immuno sorbent assay.","timeFrame":"one year"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Guidelines prepared by the diagnostic criteria(according to the diagnostic criteria of the Fourth National Stroke Conference prepared,have been more than one times skull CT and/or MRI)was confirmed for ischemic stroke,and requires the use of antithrombotic therapy(including thrombolysis, anticoagulation, antiplatelet) patients\n* Willing and able to comply with the study protocol and visits planned\n\nExclusion Criteria:\n\n* At the same time the presence of other active malignancy.\n* There is known brain metastases or leptomeningeal metastases\n* Systemic active infection ( ie infection leads to body temperature ≥38 ℃)\n* The last 4 weeks there is a need drainage ascites, pleural effusion or pericardial fluid .\n* Clinically significant obstruction , pulmonary fibrosis , kidney failure , liver failure and other diseases.\n* Uncontrolled diabetes.\n* Severe / unstable angina, New York Heart Association (NYHA) class III or IV symptoms of congestive heart failure\n* there is other reason (not the antithrombotic drugs) caused by bleeding.\n* The presence of an autoimmune disease or a history of organ transplant patients require immunosuppressive therapy\n* Psychiatric presence may increase the risks associated with study participation or study drug , or may interfere with the interpretation of study results\n* Pregnant and lactating women\n* Bleeding disorders may exist on admission\n* The researchers added that the study is not appropriate to the circumstances","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"The stroke patient using Anti-thrombotic drugs diagnosed by Zhujiang Hospital.","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Yong Wang, Doctor","affiliation":"clinical drug trial institution","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Zhujiang Hospital of Southern Medical University","city":"Guangzhou","state":"Guangdong","zip":"510000","country":"China","geoPoint":{"lat":23.11667,"lon":113.25}}]},"ipdSharingStatementModule":{"ipdSharing":"YES"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000006470","term":"Hemorrhage"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M9246","name":"Hemorrhage","asFound":"Bleeding","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9243","name":"Hemophilia A","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T2711","name":"Hemophilia A","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC15","name":"Blood and Lymph Conditions"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M8002","name":"Factor VIII","relevance":"LOW"}],"browseBranches":[{"abbrev":"Coag","name":"Coagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}